Leslie T. Cooper, M.D., is the Elizabeth C. Lane and M. Nadine Zimmerman Professor of Internal Medicine and the chair of the Department of Cardiovascular Medicine at Mayo Clinic in Florida. Dr. Cooper's clinical interests and research focus on clinical and translational studies of rare and undiagnosed cardiomyopathies, myocarditis, inflammatory cardiac and vascular diseases such as giant cell myocarditis, cardiac sarcoidosis, eosinophilic myocarditis, and Takayasu's arteritis. He has published over 200 original peer-reviewed papers and over 100 book chapters, review articles and editorials on myocarditis. In addition, he has worked with clinicians and researchers around the world to further diagnosis, treatment, and care for myocarditis and cardiomyopathies. In addition to his clinical and research work, Dr. Cooper is a fellow of the American College of Cardiology, the American Heart Association, the European Society of Cardiology Heart Failure Association, the International Society for Heart and Lung Transplantation, and the Society for Vascular Medicine and Biology. He is also the founder and former president of the Myocarditis Foundation and continues to serve on their board of directors.

Professor Susanna Price is a consultant cardiologist and intensivist based at Royal Brompton Hospital. She trained at King's College London, and continued training in cardiology and intensive care medicine at a number of centres, including St Thomas', St George's and Royal Brompton hospitals, London. During her cardiology training, she undertook a fellowship in echocardiography at the Thoraxcenter under Jos Roelandt. On completion of her training, she was awarded the Jill Dando GUCH fellowship, allowing her to train for a further two years in imaging and management of the critically ill grown-up congenital heart disease (GUCH) patients.

Professor Liza Thomas is a Conjoint Professor at Sydney University, Adjunct Professor at University of New South Wales and is the Clinical Lead for non-invasive cardiac imaging at Westmead Hospital. Her research focuses particularly on echocardiographic evaluation of atrial dynamics and function, chemotherapy related cardiomyopathy, amyloid and Fabry cardiomyopathies and cardiac involvement in chronic kidney disease. Liza is actively involved in teaching and supervises PhD and master's students. Liza has been and invited speaker at national and international meetings and has published over 200 peer reviewed papers.

A/Prof. M Hasib Sidiqi is a consultant hematologist at Fiona Stanley Hospital in Perth and an adjunct Associate Professor through Curtin Medical School. He completed his general physician and haematology training at Royal Perth and Sir Charles Gairdner hospital before undertaking a 2 year fellowship at the Mayo Clinic Rochester in Myeloma, Amyloidosis and Transplantation. His clinical interests are optimizing treatment outcomes for patients with Myeloma and Amyloidosis through an expanded clinical trial program focusing on immunotherapy. He is the plasma cell lead and part of the CAR-T cell group at Fiona Stanley. He is a member of the AMaRC Research Advisory Group and myeloma working party of the ALLG.

Felicity is a heart failure and transplant cardiologist at Fiona Stanley Hospital in Perth. She also has interests in echocardiography, mechanical circulatory support and cardiogenic shock. She completed her cardiology training in Western Australia and did a 2-year fellowship in advanced heart failure and echocardiography at The University of Ottawa Heart Institute. She remains passionate about teaching and actively participates in clinical research.

Dr Jay Baumwol has an interest in cardiomyopathy, advanced heart failure, cardiac transplantation, mechanical circulatory support, cardiac amyloidosis, and echocardiography. He graduated medicine with honours from the University of Western Australia, and has undertaken further training at St Vincent’s Hospital Sydney, Toronto General Hospital and Mount Sinai Hospital Toronto, Canada. He is a member of the WA Advanced Heart Failure and Cardiac Transplant Service at Fiona Stanley Hospital, Perth.

Prof McGiffin has now retired from cardiothoracic surgical practice which was dominated by thoracic transplantation, mechanical circulatory support and pulmonary endarterectomy. However, he continues to be active in research involving donor heart preservation with machine perfusion, developing an infection resistant driveline for ventricular assist devices and modelling of CTEPH physiology.